Pharmedic Pharmaceutical Medicinal Joint Stock Company

HNX:PMC Stock Report

Market Cap: ₫896.9b

Pharmedic Pharmaceutical Medicinal Past Earnings Performance

Past criteria checks 6/6

Pharmedic Pharmaceutical Medicinal has been growing earnings at an average annual rate of 3.4%, while the Pharmaceuticals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 1.5% per year. Pharmedic Pharmaceutical Medicinal's return on equity is 26.1%, and it has net margins of 12.7%.

Key information

3.4%

Earnings growth rate

2.9%

EPS growth rate

Pharmaceuticals Industry Growth13.0%
Revenue growth rate1.5%
Return on equity26.1%
Net Margin12.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pharmedic Pharmaceutical Medicinal makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

HNX:PMC Revenue, expenses and earnings (VND Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24493,36762,50989,3290
30 Jun 24516,73861,78289,2570
31 Mar 24483,23760,54385,7420
31 Dec 23485,18661,00285,6450
30 Sep 23479,79359,34385,2050
30 Jun 23455,20558,95887,2920
31 Mar 23458,68157,57491,1780
31 Dec 22472,27460,89495,5880
30 Sep 22484,46967,38196,8120
30 Jun 22408,97450,04479,2130
31 Mar 22414,45648,42677,4390
31 Dec 21414,23247,27574,9120
30 Sep 21404,78839,49773,7170
30 Jun 21470,85254,87289,3430
31 Mar 21448,82151,18287,8370
01 Jan 21460,76454,47190,8010
30 Sep 20457,84355,10192,7090
30 Jun 20462,43755,89993,6020
31 Mar 20480,47757,59195,2820
01 Jan 20464,77254,32792,3150
30 Sep 19457,77853,69591,6780
30 Jun 19453,92752,53390,2130
31 Mar 19451,77652,12390,0640
31 Dec 18454,57253,76492,4880
30 Sep 18444,01853,13391,3750
30 Jun 18443,79754,62893,8800
31 Mar 18432,68554,03593,1380
31 Dec 17429,60253,10194,2430
30 Sep 17430,90153,61896,6190
30 Jun 17424,09153,51396,0230
31 Mar 17425,20954,46897,0980
31 Dec 16413,93753,97194,1520
30 Sep 16409,11454,85191,6200
30 Jun 16403,98552,51290,8290
31 Mar 16398,97549,50588,2150
31 Dec 15387,65946,66486,5580
30 Sep 15380,49446,44586,4550
30 Jun 15371,14045,05384,2580
31 Mar 15367,58545,42685,4490
31 Dec 14363,47645,50085,0900
30 Sep 14365,58661,95884,0540
30 Jun 14366,44460,81882,9880
31 Mar 14363,93658,83280,8520
31 Dec 13357,36255,63377,4840

Quality Earnings: PMC has high quality earnings.

Growing Profit Margin: PMC's current net profit margins (12.7%) are higher than last year (12.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PMC's earnings have grown by 3.4% per year over the past 5 years.

Accelerating Growth: PMC's earnings growth over the past year (5.3%) exceeds its 5-year average (3.4% per year).

Earnings vs Industry: PMC earnings growth over the past year (5.3%) exceeded the Pharmaceuticals industry -11.5%.


Return on Equity

High ROE: PMC's Return on Equity (26.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies